The Oncology Institute Inc. share price logo

The Oncology Institute Inc.

NASDAQ: TOI

$5.13

+0.27

(+5.56%)

as on

Bell Icon

This instrument is not available for trading on the INDmoney app on 3 Aug 2026

The Oncology Institute Inc. Stock Performance

as on August 4, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $4.87
    $5.15
    downward going graph

    5.07%

    Downside

    0.39%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.32
    $6.67
    downward going graph

    54.78%

    Downside

    30.02%

    Upside

    downward going graph

The Oncology Institute Inc. share price movements today

Previous Close
$4.86
Open
$4.94
Volume
1.2M
Day's Low - High
$4.87 - $5.15
52 Week Low - High
$2.32 - $6.67

The Oncology Institute Inc. Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

The Oncology Institute Inc. Stock Fundamentals & Key Indicators

Check The Oncology Institute Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

0.00%

The Oncology Institute Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of The Oncology Institute Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
The Oncology Institute Inc. image
The Oncology Institute Inc.
BUY$-NANA0.00%NA
Tenet Healthcare image
Tenet Healthcare
BUY$21.5B254.08%10.3510.27%NA
DaVita image
DaVita
HOLD$11.5B38.17%15.2931.02%NA
Encompass Health image
Encompass Health
BUY$11.9B54.05%19.9810.01%63.260000000000005%
HCA Healthcare image
HCA Healthcare
BUY$92.8B65.16%14.068.77%70.23%
See all

Analyst Recommendation on The Oncology Institute Inc. Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for The Oncology Institute Inc.. Average target price of $8.4

The Oncology Institute Inc. Share Price Target

Get share price movements and forecasts by analysts on The Oncology Institute Inc..

What analysts predicted

38.93%UPSIDE

Target Price

$8.4

Current Price

$5.13

Analyzed by

5 Analysts

Target

$8.40

The Oncology Institute Inc. target price $8.4, a slight upside of 38.93% compared to current price of $5.13. According to 5 analysts rating.

The Oncology Institute Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
85
94
98
99
100
104
119
136
141
147
Gross Profit
14
11
13
14
14
17
17
18
22
21
Operating Income
-
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-18
-19
-15
-16
-13
-19
-17
-16
-7
-2
Net Profit Margin
-21.86%
-21.01%
-15.70%
-16.13%
-13.15%
-18.76%
-14.20%
-12.09%
-5.29%
-1.69%

The Oncology Institute Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
113
155
187
203
252
324
393
502
Gross Profit
26
29
36
40
52
59
53
76
Operating Income
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
Net Income
3
-4
-14
-10
0
-83
-64
-60
Net Profit Margin
3.49%
-2.59%
-7.64%
-5.38%
0.06%
-25.62%
-16.44%
-12.06%

Global Institutional Holdings in The Oncology Institute Inc.

Funds
Holdings
Kanen Wealth Management LLC
2.78%
JOSH ARNOLD INVESTMENT CONSULTANT, LLC
2.46%
TIFF Advisory Services Inc
3.89%
State Street Corp
1.46%
Arrowstreet Capital Limited Partnership
0.42%
See all

The Oncology Institute Inc. News & Key Events

  • img

    Today's Timeline - 07 July

    Tue, 06:30 PM

    -

    Oncology Institute repays $86 million convertible note with new $75 million term loan from OrbiMed, enhancing liquidity and extending debt maturities.

Insights on The Oncology Institute Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, TOI has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, TOI stock has moved up by 98.1%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 21 quarters, 48.57M → 147.44M (in $), with an average increase of 5.3% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 5 quarters, -19.58M → -2.49M (in $), with an average increase of 84.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, DaVita Inc. has given 67.5% return, outperforming this stock by 40.2%

About The Oncology Institute Inc.

The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
OrganisationThe Oncology Institute Inc.
E-voting on sharesClick here to vote

FAQs

What is The Oncology Institute Inc. share price today?

The Oncology Institute Inc. share price today is $5.13 as on at the close of the market. The Oncology Institute Inc. share today touched a day high of $5.15 and a low of $4.87.

What is the 52 week high and 52 week low for The Oncology Institute Inc. share?

The Oncology Institute Inc. share touched a 52 week high of $6.67 on and a 52 week low of $2.32 on . The Oncology Institute Inc. stock price today i.e. is closed at $5.13,which is 23.09% down from its 52 week high and 121.12% up from its 52 week low.

How to invest in The Oncology Institute Inc. Stock (TOI) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for The Oncology Institute Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in The Oncology Institute Inc. Shares that will get you 0.2924 shares as per The Oncology Institute Inc. share price of $5.13 per share as on August 4, 2026 at 8:46 am IST.

What is the minimum amount required to buy The Oncology Institute Inc. Stock (TOI) from India?

Indian investors can start investing in The Oncology Institute Inc. (TOI) shares with as little as ₹95.152 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹951.52 in The Oncology Institute Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on The Oncology Institute Inc. share’s latest price of $5.13 as on August 4, 2026 at 8:46 am IST, you will get 1.9493 shares of The Oncology Institute Inc.. Learn more about fractional shares .